International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8006833
Original Article
Comparative Study of Effectiveness of POMPP, Boey and Pulp Scoring Systems in Assessment of Severity in Peptic Ulcer Perforation Patients: Prospective Study
 ,
 ,
 ,
 ,
Published
June 5, 2023
Abstract
Background: Peptic ulcer perforation remains a significant clinical problem with high morbidity and mortality rates. Several scoring systems have been proposed for assessing the severity of peptic ulcer perforation, including the Boey, POMPP, and PULP scores. This study aimed to compare the effectiveness of these scoring systems in predicting postoperative morbidity and mortality. Methods: This prospective study included 60 patients with peptic ulcer perforation who underwent surgery. The Boey, POMPP, and PULP scores were calculated for each patient. The sensitivity, specificity and accuracy of each scoring system in predicting postoperative morbidity and mortality were compared. Results: The PULP score was found to be a better tool for assessing the severity in peptic ulcer perforation patients compared to the Boey and POMPP scores. In patients with severe perforated peptic ulcer the PULP score had a higher sensitivity (88.9%) and accuracy (78.3%) in predicting postoperative morbidity and mortality. The Boey score had a lower sensitivity (77.8%) and accuracy (68.3%), while the POMPP score had a lower sensitivity (66.7%) and accuracy (60.0%). Conclusion: The PULP score may be a more effective tool for assessing the severity in peptic ulcer perforation patients compared to the Boey and POMPP scores. Factors that may affect the accuracy of each scoring system were also identified. Further studies with larger sample sizes and a wider range of scoring systems are needed to confirm these findings.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1106 Views
207 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved